Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1

Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1

Abstract Lung adenocarcinoma is the major subtype of lung cancer, accounting for approximately 40% of lung cancers. During clinical treatment, the emergence of chemotherapy resistance seriously affects the effectiveness of treatment. Thus, finding new chemotherapeutic sensitizers is considered to be...

Full description

Bibliographic Details
Main Authors: Jianjun Li, Yaqi Kou, Xiaohan Zhang, Xuechun Xiao, Yang Ou, Lixia Cao, Min Guo, Chunchun Qi, Zhaoyang Wang, Yuxin Liu, Qiuying Shuai, Hang Wang, Shuang Yang
Format: Article
Language:English
Published: Springer 2022-12-01
Series:Discover Oncology
Subjects:
Lung adenocarcinoma
Biochanin A
ZEB1
Chemosensitization
Proteasomal ubiquitination
Online Access:https://doi.org/10.1007/s12672-022-00601-2

Internet

https://doi.org/10.1007/s12672-022-00601-2

Similar Items